Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
Baumbach A, Mullen M, Brickman AM, Aggarwal SK, Pietras CG, Forrest JK, Hildick-Smith D, Meller SM, Gambone L, den Heijer P, Margolis P, Voros S, Lansky AJ. Baumbach A, et al. Among authors: den heijer p. EuroIntervention. 2015 May;11(1):75-84. doi: 10.4244/EIJY15M04_01. EuroIntervention. 2015. PMID: 25868876 Free article. Clinical Trial.
Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval.
Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Piazza N, et al. Among authors: den heijer p. EuroIntervention. 2008 Aug;4(2):242-9. doi: 10.4244/eijv4i2a43. EuroIntervention. 2008. PMID: 19110790
Real-world multicentre experience with the Direct Flow Medical repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis.
Naber CK, Pyxaras SA, Ince H, Latib A, Frambach P, den Heijer P, Wagner D, Butter C, Colombo A, Kische S. Naber CK, et al. Among authors: den heijer p. EuroIntervention. 2016 Feb;11(11):e1314-20. doi: 10.4244/EIJV11I11A254. EuroIntervention. 2016. PMID: 26865450 Free article.
Four-year experience with the CoreValve transcatheter heart valve.
Kovac J, Schuler G, Gerckens U, Müller R, Serruys PW, Bonan R, Labinaz M, den Heijer P, Mullen M, Tymchak W, Grube E. Kovac J, et al. Among authors: den heijer p. EuroIntervention. 2016 Oct 10;12(8):e1039-e1046. doi: 10.4244/EIJY15M10_10. EuroIntervention. 2016. PMID: 27159659 Free article.
A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis.
Naber CK, Pyxaras SA, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, Den Heijer P, Schillinger W, Scholtz S, Van der Heyden J, Lefèvre T, Gilard M, Kuck KH, Schofer J, Divchev D, Baumgartner H, Asch F, Wagner D, Latib A, De Marco F, Kische S. Naber CK, et al. Among authors: den heijer p. EuroIntervention. 2016 Dec 10;12(11):e1413-e1419. doi: 10.4244/EIJ-D-15-00511. EuroIntervention. 2016. PMID: 27934611 Free article. Clinical Trial.
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP; SURTAVI Investigators. Reardon MJ, et al. N Engl J Med. 2017 Apr 6;376(14):1321-1331. doi: 10.1056/NEJMoa1700456. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304219 Free article. Clinical Trial.
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial.
Van Mieghem NM, Popma JJ, Deeb GM, Yakubov SJ, Serruys PW, Windecker S, Søndergaard L, Mumtaz M, Gada H, Chetcuti S, Kleiman NS, Kodali S, George I, Teefy P, Kiaii B, Oh JK, Kappetein AP, Chang Y, Mugglin AS, Reardon MJ; SURTAVI Trial Investigators. Van Mieghem NM, et al. JACC Cardiovasc Interv. 2020 Feb 10;13(3):323-331. doi: 10.1016/j.jcin.2019.10.043. JACC Cardiovasc Interv. 2020. PMID: 32029248 Free article. Clinical Trial.
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.
Van Mieghem NM, Deeb GM, Søndergaard L, Grube E, Windecker S, Gada H, Mumtaz M, Olsen PS, Heiser JC, Merhi W, Kleiman NS, Chetcuti SJ, Gleason TG, Lee JS, Cheng W, Makkar RR, Crestanello J, George B, George I, Kodali S, Yakubov SJ, Serruys PW, Lange R, Piazza N, Williams MR, Oh JK, Adams DH, Li S, Reardon MJ; SURTAVI Trial Investigators. Van Mieghem NM, et al. JAMA Cardiol. 2022 Oct 1;7(10):1000-1008. doi: 10.1001/jamacardio.2022.2695. JAMA Cardiol. 2022. PMID: 36001335 Free PMC article. Clinical Trial.
133 results